Fresh frozen plasma as a complement source
- 1 May 2007
- journal article
- reflection and-reaction
- Published by Elsevier BV in The Lancet Oncology
- Vol. 8 (5), 370-371
- https://doi.org/10.1016/s1470-2045(07)70114-6
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Addition of fresh frozen plasma as a source of complement to rituximab in advanced chronic lymphocytic leukaemiaThe Lancet Oncology, 2007
- Thrice-Weekly Low-Dose Rituximab Decreases CD20 Loss via Shaving and Promotes Enhanced Targeting in Chronic Lymphocytic LeukemiaPublished by The American Association of Immunologists ,2006
- Rituximab Infusion Promotes Rapid Complement Depletion and Acute CD20 Loss in Chronic Lymphocytic LeukemiaPublished by The American Association of Immunologists ,2004
- The Biology of CD20 and Its Potential as a Target for mAb TherapyCurrent directions in autoimmunity, 2004
- An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximabBlood, 2003
- Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysisBlood, 2000